These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12894712)

  • 1. [Multi-center trial of gemcitabine for 49 patients with advanced pancreatic cancer].
    Sumii T; Funakoshi A; Ito T; Mizumoto K; Tanaka M; Migita Y; Sakai T; Shinozaki H; Yamaguchi H; Niyahara T; Muranaka T; Eriguchi N; Ueki T;
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):971-6. PubMed ID: 12894712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of postoperative adjuvant chemotherapy with gemcitabine for pancreatic cancer: feasibility and anti-tumor effect].
    Kurosaki I; Tsuchiya Y; Shimizu T; Hatakeyama K
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1201-4. PubMed ID: 15332543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of gemcitabine therapy for recurrent or metastatic pancreatic cancer].
    Moriwaki T; Hyodo I; Nishina T; Nasu J; Hidaka S; Kajiwara T; Tsuzuki T; Hirao K; Tsubouchi E; Yamauchi Y; Hirasaki S; Masumoto T; Tanada M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1373-6. PubMed ID: 15446559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
    Small W; Berlin J; Freedman GM; Lawrence T; Talamonti MS; Mulcahy MF; Chakravarthy AB; Konski AA; Zalupski MM; Philip PA; Kinsella TJ; Merchant NB; Hoffman JP; Benson AB; Nicol S; Xu RM; Gill JF; McGinn CJ
    J Clin Oncol; 2008 Feb; 26(6):942-7. PubMed ID: 18281668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.
    Wolff RA; Evans DB; Gravel DM; Lenzi R; Pisters PW; Lee JE; Janjan NA; Charnsangavej C; Abbruzzese JL
    Clin Cancer Res; 2001 Aug; 7(8):2246-53. PubMed ID: 11489798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies.
    Fleming DR; Glisson SD; Bhupalam L; Michelson GD; Goldsmith GH; LaRocca RV
    Am J Clin Oncol; 2000 Aug; 23(4):349-52. PubMed ID: 10955861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
    Von Hoff DD; Ervin T; Arena FP; Chiorean EG; Infante J; Moore M; Seay T; Tjulandin SA; Ma WW; Saleh MN; Harris M; Reni M; Dowden S; Laheru D; Bahary N; Ramanathan RK; Tabernero J; Hidalgo M; Goldstein D; Van Cutsem E; Wei X; Iglesias J; Renschler MF
    N Engl J Med; 2013 Oct; 369(18):1691-703. PubMed ID: 24131140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer.
    Cengiz M; Zorlu F; Yalcin S; Gurkaynak M; Atahan IL; Gullu IH
    Med Oncol; 2007; 24(2):239-43. PubMed ID: 17848750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant systemic chemotherapy with gemcitabine for stage IV pancreatic cancer: a preliminary report of initial experience.
    Kurosaki I; Hatakeyama K
    Chemotherapy; 2005 Oct; 51(6):305-10. PubMed ID: 16224180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancer.
    Lipton A; Campbell-Baird C; Witters L; Harvey H; Ali S
    J Clin Gastroenterol; 2010 Apr; 44(4):286-8. PubMed ID: 20216081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.
    Abou-Alfa GK; Letourneau R; Harker G; Modiano M; Hurwitz H; Tchekmedyian NS; Feit K; Ackerman J; De Jager RL; Eckhardt SG; O'Reilly EM
    J Clin Oncol; 2006 Sep; 24(27):4441-7. PubMed ID: 16983112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
    Cao C; Kuang M; Xu W; Zhang X; Chen J; Tang C
    Jpn J Clin Oncol; 2015 Dec; 45(12):1122-30. PubMed ID: 26518328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer.
    Tomao S; Romiti A; Massidda B; Ionta MT; Farris A; Zullo A; Brescia A; Santuari L; Frati L
    Anticancer Res; 2002; 22(4):2361-4. PubMed ID: 12174927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial.
    Girard N; Mornex F; Bossard N; Ychou M; Chauffert B; Wautot V
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1426-32. PubMed ID: 20056351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical problems in gemcitabine treatment for unresectable pancreatic cancer in the elderly--a multicentric retrospective study of 53 cases].
    Takeuchi N; Maejima S; Hasebe O; Matsuda Y; Hanazaki K; Kajikawa S; Mukawa K; Hosokawa K; Hayashi K; Hisa T; Furut K; Tajiri K; Fujimori Y; Kaneko G; Ochi Y; Shikama N; Kawa S; Miyagawa S; Miwa S; Kiyosawa K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1987-91. PubMed ID: 15570926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer and leukemia group B (CALGB) 89805: phase II chemoradiation trial using gemcitabine in patients with locoregional adenocarcinoma of the pancreas.
    Blackstock AW; Tepper JE; Niedwiecki D; Hollis DR; Mayer RJ; Tempero MA
    Int J Gastrointest Cancer; 2003; 34(2-3):107-16. PubMed ID: 15361643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.
    Bramhall SR; Schulz J; Nemunaitis J; Brown PD; Baillet M; Buckels JA
    Br J Cancer; 2002 Jul; 87(2):161-7. PubMed ID: 12107836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancer.
    Furuse J; Ishii H; Okusaka T; Nagase M; Nakachi K; Ueno H; Ikeda M; Morizane C; Yoshino M
    Jpn J Clin Oncol; 2005 Dec; 35(12):733-8. PubMed ID: 16303793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study.
    Park SJ; Kim H; Shin K; Hong TH; Suh JH; Lee MA
    BMC Cancer; 2021 Nov; 21(1):1176. PubMed ID: 34732161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.
    Ikeda M; Okada S; Tokuuye K; Ueno H; Okusaka T
    Br J Cancer; 2002 May; 86(10):1551-4. PubMed ID: 12085203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.